Dr.S.Imam Pasha

@sucp.ac.in

Associate Professor/Pharmaceutical Quality Assurance
Sultan -ul-Uloom College of Pharmacy



                 

https://researchid.co/impazam

EDUCATION

PhD(Pharmaceutical Analysis & Quality Assurance) from Jawaharlal Nehru Technological University, Hyderabad.
-
M. Pharmacy(Pharmaceutical Quality Assurance) from Jawaharlal Nehru Technological University, Hyderabad ,First Class with Distinction (87%).
B. Pharmacy from Jawaharlal Nehru Technological University, Hyderabad,First Division (75.2%)
Intermediate-MPC(10+2),Board of Intermediate Education, Hyderabad,First Division (90%)
SSC(10th ),Board of Secondary Education, Hyderabad, Telangana State, India,First Division (81%)

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacy, Analytical Chemistry, Pharmacology (medical), Chemistry

6

Scopus Publications

70

Scholar Citations

4

Scholar h-index

2

Scholar i10-index

Scopus Publications


  • Stability indicating RP-UPLC-PDA method development, validation of multi drug combination of emtricitabine,tenofovir alafenamide and rilpivirine in bulk drug & its tablet formulation
    Imam Pasha. S, Murali Balaram.Varanasi, and Ibrahim Mohammed

    Oriental Scientific Publishing Company
    Stability representing Ultra Performance LC method was developed for Assay of multi drug Combination of Rilpivirine, Emtricitabine and Tenofovir alafenamide in bulk active pharmaceutical ingredients & its tablet formulation, Validation was performed for all parameters .Retention times of Reference Standard Emtricitabine, Tenofovir Alafenamide and Rilpivirine was found to be 0.965, 1.528, 2.186 respectively, with the flow rate of 0.3 mille liters per minute by Injecting Volume of 2 micro liters by maintaining Run time of 3 minutes. Developed method was subjected to forced degradation studies under specified conditions, which meets the required criteria. Degradation product at 1.975 Rt was collected under various stress condition, cleavage of imidazole ring of tenafovir alafenamide confirmed with Proton NMR, ESI –MASS in + MODE.

  • Miniaturization in rational drug design of pharmaceuticals: A review
    Ghazala Yasmeen, Mohd Ibrahim, V Balram, S Pasha, Sadaf Rahman, and Mohsina Abid

    Oriental Scientific Publishing Company
    Miniaturization in High Throughput Screening (HTS) is perceived as essential by pharmaceutical screening laboratories to accommodate the enormous increase in compounds and targets over the past few years. The two primary goals are to increase throughput while decreasing costs. The ability to perform primary screening assays in high-density micro-well plates at volumes of 1–2μl will accelerate the early stages of drug discovery. Ultra-HTS (uHTS) assays require an accurate and reliable means of fluid handling in the submicroliter volume range. This relates to the design of instrumentation for dispensing fluids, as well as assay plates. Fluid handling has been a major obstacle to the full implementation of miniaturized assays. This report focuses on current approaches to submicroliter fluid handling in high-density multi-well plates.

  • Development and validation of a new RP-HPLC method for simultaneous estimation of N-acetylcysteine and L-arginine in combined dosage form
    Nalluri Jyothi and Syed Pasha

    Oriental Scientific Publishing Company
    An isocratic, reversed phase-liquid chromatographic method was developed for quantitative determination of N-acetylcysteine and L-Arginine in combined dosage form. A Waters Xterra Rp8, (150*4.6*5µm) column with a mobile phase containing a Phosphate Buffer (pH 4.5) and Methanol (90: 10 v/v) was used. The flow rate was maintained at 0.8 ml/min, column temperature at 30°C and effluents were monitored at 248 nm. The retention times of N-acetylcysteine and L-Arginine were found to be 2.697 min and 3.156 min, respectively. The correlation co-efficient for N-acetylcysteine and L-Arginine was found to be 0.99 and 0.99, respectively. The proposed method was validated with respect to linearity, accuracy, precision, specificity, and robustness. Recovery of N-acetylcysteine and L-Arginine in formulations was found to be in the range of 97-103% and 97-103% respectively confirms the non-interferences of the excipients in formulation. Due to its simplicity, rapidness and high precision, this method can be successfully applied for estimation of N-acetylcysteine and L-Arginine in combined pharmaceutical dosage forms.

  • RP HPLC method development and validation for estimatation of isradipine in tablet dosage form


  • New visible spectrophotometric method for the determination of cefixime trihydrate in pharmaceutical formulations
    S.Imam pasha, Shravan kumar A, K. Sravanthi, G. Srinika, and V. Nikhila

    Oriental Scientific Publishing Company
    A simple, sensitive and economical spectrophotometric method was developed for the determination of cefixime trihydrate in pharmaceutical formulations. This method is based on the formation of pink colored chromogen complex by the reaction of drug with ferric chloride and 2, 2 bipyridyl, which absorbs maximally at 520 nm. Beer’s law is obeyed at a concentration range of 110 mcg/ml for method. This method has been successfully applied for the assay of the drug in pharmaceutical formulations.

RECENT SCHOLAR PUBLICATIONS

  • In Silico Docking Analysis and Admet Prediction of Thymoquinone Derivatives Against Ovarian Cancer.
    M Azmi, IP Syed, A Koneru
    Oriental Journal of Chemistry 37 (1) 2021

  • Development and validation of stability indicating RP-HPLC method for estimation of larotrectinib in its formulations
    M Fatima, A Koneru, MMA Khan, MB Varanasi, IP Syed
    Oriental Journal of Chemistry 36 (2), 327 2020

  • Synthesis of acridone base phenolic compounds for antibacterial activity
    A Begum, SI Pasha, SS Fatima
    Organic & Medicinal Chemistry International Journal 9 (2), 32-46 2019

  • Analytical method validation for the identification and determination of limit of Urea by HPLC in 2, 4 -Dihydroxy -5 –Fluoropyrimidine injection
    MBV Imam Pasha.S, Ibrahim Mohammed
    International Journal of Medicinal Chemistry & Analysis 7 (1), 1-10 2017

  • Bio analysis of Monomethyl Fumarate in human plasma by a sensitive and rapid LC-MS/MS method and its pharmacokinetic application
    MBV Imam Pasha.S, Ibrahim Mohammed
    Journal of Pharmaceutical and Biomedical Analysis 146 (1), 109-116 2017

  • Stability indicating RP-UPLC-PDA method development, validation of multi drug combination of emtricitabine, tenofovir alafenamide and rilpivirine in bulk drug and its tablet
    SI Pasha, MB Varanasi, I Mohammed
    Oriental Journal of Chemistry 33 (2), 925-929 2017

  • Medicinal Chemistry & Analysis
    SI Pasha, VM Balaram, M Ibrahim
    2016

  • Miniaturization In Rational Drug Design of Pharmaceuticals: A Review
    G Yasmeen, M Ibrahim, VM Balram, SI Pasha, S Rahman, M Abid
    Oriental Journal of Chemistry 32 (2), 1265-1269 2016

  • Development and validation of a new RP-HPLC method for simultaneous estimation of N-Acetylcysteine and L-Arginine in combined dosage form
    NN Jyothi, SI Pasha
    Oriental Journal of Chememistry 30 (3), 1371-1378 2014

  • Rapid sensitive validated UPLC–MS method for determination of venlafaxine and its metabolite in rat plasma: Application to pharmacokinetic study
    SK Dubey, RN Saha, H Jangala, S Pasha
    Journal of pharmaceutical analysis 3 (6), 466-471 2013

  • RP-HPLC method development and validation for estimatation of isradipine in tablet dosage form
    M Younus, I Pasha.S., M Siddiq, A P, Lakshmi
    Asian Journal of Pharmaceutical and Clinical Research 6 (1), 140-142 2013

  • New chiral reverse phase HPLC method for enantioselective analysis of ketorolac using chiral AGP column
    SK Dubey, J Hemanth, RN Saha, S Pasha
    Journal of pharmaceutical analysis 2 (6), 462-465 2012

  • Development of Stability Indicating, Validated Liquid Chromatographic Method for Estimation of Sarecycline in its Formulations
    MBVIPS 4. Azmath unissa, Anupama Koneru, M.mushraff Ali Khan
    Oriental Journal of Chemistry 35 (6), 1805-1812

MOST CITED SCHOLAR PUBLICATIONS

  • Rapid sensitive validated UPLC–MS method for determination of venlafaxine and its metabolite in rat plasma: Application to pharmacokinetic study
    SK Dubey, RN Saha, H Jangala, S Pasha
    Journal of pharmaceutical analysis 3 (6), 466-471 2013
    Citations: 25

  • New chiral reverse phase HPLC method for enantioselective analysis of ketorolac using chiral AGP column
    SK Dubey, J Hemanth, RN Saha, S Pasha
    Journal of pharmaceutical analysis 2 (6), 462-465 2012
    Citations: 18

  • Development and validation of a new RP-HPLC method for simultaneous estimation of N-Acetylcysteine and L-Arginine in combined dosage form
    NN Jyothi, SI Pasha
    Oriental Journal of Chememistry 30 (3), 1371-1378 2014
    Citations: 8

  • Stability indicating RP-UPLC-PDA method development, validation of multi drug combination of emtricitabine, tenofovir alafenamide and rilpivirine in bulk drug and its tablet
    SI Pasha, MB Varanasi, I Mohammed
    Oriental Journal of Chemistry 33 (2), 925-929 2017
    Citations: 7

  • Synthesis of acridone base phenolic compounds for antibacterial activity
    A Begum, SI Pasha, SS Fatima
    Organic & Medicinal Chemistry International Journal 9 (2), 32-46 2019
    Citations: 3

  • Bio analysis of Monomethyl Fumarate in human plasma by a sensitive and rapid LC-MS/MS method and its pharmacokinetic application
    MBV Imam Pasha.S, Ibrahim Mohammed
    Journal of Pharmaceutical and Biomedical Analysis 146 (1), 109-116 2017
    Citations: 3

  • RP-HPLC method development and validation for estimatation of isradipine in tablet dosage form
    M Younus, I Pasha.S., M Siddiq, A P, Lakshmi
    Asian Journal of Pharmaceutical and Clinical Research 6 (1), 140-142 2013
    Citations: 3

  • Development and validation of stability indicating RP-HPLC method for estimation of larotrectinib in its formulations
    M Fatima, A Koneru, MMA Khan, MB Varanasi, IP Syed
    Oriental Journal of Chemistry 36 (2), 327 2020
    Citations: 1

  • Miniaturization In Rational Drug Design of Pharmaceuticals: A Review
    G Yasmeen, M Ibrahim, VM Balram, SI Pasha, S Rahman, M Abid
    Oriental Journal of Chemistry 32 (2), 1265-1269 2016
    Citations: 1

  • Development of Stability Indicating, Validated Liquid Chromatographic Method for Estimation of Sarecycline in its Formulations
    MBVIPS 4. Azmath unissa, Anupama Koneru, M.mushraff Ali Khan
    Oriental Journal of Chemistry 35 (6), 1805-1812
    Citations: 1

Publications

1. Imam Pasha.S, Ibrahim Mohammed , Murali Balaram Varanasi, Bio analysis of Monomethyl Fumarate in human plasma by a sensitive and rapid LC-MS/MS method and its pharmacokinetic application; Journal of Pharmaceutical and Biomedical Analysis(JPBA); ISSN Number :07317085;e -ISSN Number :1873264X; Source: WoS & Scopus; Impact Factor: 3.2; Volume:146 , Pages:109–116
2. Imam Pasha.S, Ibrahim Mohammed , Murali Balaram Varanasi; Stability indicating RP UPLC-PDA method development, validation of multi drug combination of Emtricitabine, Tenofovir alafenamide and Rilpivirine in bulk drug and its tablet formulation; Oriental Journal of Chemistry; ISSN-Number:0970020X; Scientific Publishers; Volume:33(2);Page No’s: 925 -929
3. Mohammad Younus; Imam M. Siddiq;A.P; Lakshmi; RP-HPLC method development and validation for estimatation of isradipine in tablet dosage form; Asian Journal of Pharmaceutical and Clinical Research; ISSN: 2455-3891 Print ISSN: 0974-2441);Volume: 6(1);2013,Page No’s :140-142.
4. Azmath unissa, Anupama Koneru, M.mushraff Ali Khan, Murali Balaram Varanasi and Imam Pasha Syed, Development of Stability Indicating, Validated Liquid Chromatographic Method for Estimation of Sarecycline in its Formulations; Oriental Journal of Chemistry; ISSN Number:0970020X; Scientific Publishers; Volume:35(6);Page No’s: 1805-1812
5. Imam Pasha.S, Ibrahim Mohammed , Murali Balaram Varanasi;Analytical method validation for the identification and determination of limit of Ur

RESEARCH OUTPUTS (PATENTS, SOFTWARE, PUBLICATIONS, PRODUCTS)

1. Indian Patent entitled “Synthesis and characterization of Vanadium complexes with Quadridentate Schiff bases”; Date of Filing: 28/06/2022; Publication Date :08/07/2022